Alto Ingredients (NASDAQ:ALTO - Get Free Report) is expected to issue its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $214.55 million for the quarter. Parties can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 5:00 PM ET.
Alto Ingredients (NASDAQ:ALTO - Get Free Report) last issued its earnings results on Wednesday, March 4th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.17. The business had revenue of $231.97 million for the quarter, compared to analysts' expectations of $234.83 million. Alto Ingredients had a return on equity of 2.99% and a net margin of 1.45%. On average, analysts expect Alto Ingredients to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Alto Ingredients Stock Performance
Shares of NASDAQ ALTO opened at $5.28 on Wednesday. The company has a quick ratio of 1.60, a current ratio of 2.64 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $408.09 million, a price-to-earnings ratio of 33.00 and a beta of 0.05. The stock's fifty day simple moving average is $4.20 and its 200 day simple moving average is $2.94. Alto Ingredients has a 52-week low of $0.80 and a 52-week high of $5.58.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. Truffle Hound Capital LLC purchased a new position in Alto Ingredients in the fourth quarter valued at about $864,000. Corsair Capital Management L.P. purchased a new position in Alto Ingredients in the fourth quarter valued at about $721,000. Bridgeway Capital Management LLC grew its stake in Alto Ingredients by 7.3% in the third quarter. Bridgeway Capital Management LLC now owns 522,666 shares of the company's stock valued at $564,000 after purchasing an additional 35,607 shares in the last quarter. GWN Securities Inc. purchased a new position in Alto Ingredients in the fourth quarter valued at about $378,000. Finally, Empowered Funds LLC grew its stake in Alto Ingredients by 8.5% in the first quarter. Empowered Funds LLC now owns 275,552 shares of the company's stock valued at $314,000 after purchasing an additional 21,626 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on ALTO. Weiss Ratings upgraded Alto Ingredients from a "sell (d-)" rating to a "hold (c-)" rating in a report on Monday, March 16th. Zacks Research upgraded Alto Ingredients from a "hold" rating to a "strong-buy" rating in a report on Thursday, March 5th. Finally, Wall Street Zen upgraded Alto Ingredients from a "buy" rating to a "strong-buy" rating in a report on Monday, March 23rd. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Buy".
Get Our Latest Report on Alto Ingredients
Alto Ingredients Company Profile
(
Get Free Report)
Alto Ingredients, Inc NASDAQ: ALTO is a diversified producer of alcohol-based products and specialty ingredients for industrial, food, beverage and personal care applications. The company’s core offering centers on ethanol produced for fuel markets, as well as an expanding portfolio of natural and organic alcohols, glycerin and other ingredient solutions. Alto’s product lines serve a range of end markets, including renewable fuels, confectionery, flavorings, cosmetics and sanitizers.
Headquartered in Dallas, Texas, Alto Ingredients operates a network of production facilities across the United States.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Alto Ingredients, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alto Ingredients wasn't on the list.
While Alto Ingredients currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.